MUCUS
Live / Applied — Statement of use — registration review complete (as of 23 Mar 2026)
What this means for you
Not registered yet, but its 31 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97340231
- Mark type
- Design + words
- Filed
- 31 Mar 2022
- Published for opposition
- 11 Jul 2023
- Attorney of record
- Mark Lerner, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds; allergy relief medication; antihistamines
Owner
- RB Health (US) LLC, Parsippany, NJ, US
- RB Health (US) LLC, Parsippany, NJ, US
Prosecution history
- 23 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Mar 2026 — USE AMENDMENT FILED
- 02 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 10 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — SOU EXTENSION 4 GRANTED
- 01 Sept 2025 — SOU EXTENSION 4 FILED
- 02 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Feb 2025 — SOU EXTENSION 3 GRANTED
- 18 Feb 2025 — SOU EXTENSION 3 FILED
- 18 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Nov 2024 — SOU EXTENSION 2 GRANTED